Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 173.85B | 179.21B | 216.26B | 218.00B | 213.40B | 191.33B |
Gross Profit | 23.62B | 23.74B | 26.84B | 19.22B | 22.67B | 19.28B |
EBITDA | 15.08B | 15.97B | 21.09B | 14.27B | 19.86B | 12.31B |
Net Income | 3.93B | 4.55B | 7.45B | 1.44B | 4.47B | -1.33B |
Balance Sheet | ||||||
Total Assets | 161.32B | 168.41B | 185.61B | 199.63B | 208.33B | 189.18B |
Cash, Cash Equivalents and Short-Term Investments | 42.16B | 42.76B | 49.16B | 33.70B | 42.07B | 34.05B |
Total Debt | 1.97B | 1.17B | 3.56B | 6.58B | 10.44B | 10.33B |
Total Liabilities | 51.16B | 56.86B | 75.79B | 102.21B | 113.36B | 103.42B |
Stockholders Equity | 101.02B | 102.16B | 100.22B | 88.18B | 83.81B | 76.03B |
Cash Flow | ||||||
Free Cash Flow | 2.18B | -135.00M | 18.79B | -354.00M | 6.21B | 8.17B |
Operating Cash Flow | 6.76B | 3.82B | 22.35B | 4.06B | 12.14B | 16.15B |
Investing Cash Flow | -3.91B | -3.48B | -3.10B | -2.81B | -3.95B | -8.69B |
Financing Cash Flow | -5.97B | -6.49B | -6.63B | -7.68B | -2.79B | -625.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥163.99B | 12.51 | 7.93% | 2.14% | -1.29% | -26.66% | |
81 Outperform | ¥162.95B | 10.29 | 8.79% | 5.01% | 2.11% | 16.65% | |
80 Outperform | ¥122.39B | 10.34 | 9.74% | 3.52% | 1.71% | -11.98% | |
77 Outperform | ¥202.81B | 8.40 | 10.18% | 2.85% | -0.17% | 72.81% | |
72 Outperform | ¥45.12B | 11.49 | ― | 2.36% | -18.46% | -48.08% | |
70 Outperform | ¥88.22B | 13.66 | 5.28% | 3.86% | -11.96% | -46.82% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |